Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Across age groups, current GLP-1 use is highest among those who are between the ages of 50 and 64 (22%), with smaller shares of those ages 18-29 (4%), 30-49 (11%), or over age 65 (9%) saying they are currently using these drugs
Note: Semaglutide is not yet available in Singapore and is expected to be in stock from 2026 onwards
based on clinical suitability and your health goals
The research base draws on Phase 2/3 trials, mechanistic studies, and metabolic outcomes research across multiple institutions
Its cagrilintide component provides the only clinical-grade tool for studying long-acting amylin receptor agonism in combination with GLP-1 signaling
US$ 25.33
US$ 27.81
US$ 21.60
